99
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Inhaled Steroids, Sex and Emphysema Index – Clinical Parameters with Impact on the Effectiveness of Valve Implantation in Patients with Severe Emphysema

, , , , , , , , ORCID Icon & show all
Pages 1423-1430 | Published online: 20 Jun 2022

References

  • Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob Health Epidemiol Genom. 2018;3:e4. doi:10.1017/gheg.2018.1
  • Shaker SB, Stavngaard T, Hestad M, Bach KS, Tonnesen P, Dirksen A. The extent of emphysema in patients with COPD. Clin Respir J. 2009;3(1):15–21. doi:10.1111/j.1752-699X.2008.00102.x
  • Devasahayam J, LaFreniere K, Naik R. Chronic emphysema. [ Updated 2021 Aug 9]. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539910/. Accessed June 9, 2022.
  • Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume- reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348:2059–2073.
  • Klooster K, ten Hacken NH, Hartman JE, Kerstjens HA, van Rikxoort EM, Slebos DJ. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med. 2015;373(24):2325–2335. doi:10.1056/NEJMoa1507807
  • Kemp SV, Slebos DJ, Kirk A, et al. A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med. 2017;196:1535–1543. doi:10.1164/rccm.201707-1327OC
  • Herth FJF, Slebos DJ, Criner GJ, Valipour A, Sciurba F, Shah PL. Endoscopic lung volume reduction: an expert panel recommendation - update 2019. Respiration. 2019;97(6):548–557. doi:10.1159/000496122
  • Valipour A, Slebos DJ, Herth F, et al.; IMPACT Study Team. Endobronchial valve therapy in patients with homogeneous emphysema. Results from the IMPACT Study . Am J Respir Crit Care Med. 2016;194(9):1073–1082. doi:10.1164/rccm.201607-1383OC
  • Eberhardt R, Gompelmann D, Herth FJ, Schuhmann M. Endoscopic bronchial valve treatment: patient selection and special considerations. Int J Chron Obstruct Pulmon Dis. 2015;10:2147–2157. doi:10.2147/COPD.S63473
  • Gompelmann D, Hofbauer T, Gerovasili V, et al. Predictors of clinical outcome in emphysema patients with atelectasis following endoscopic valve therapy: a retrospective study. Respirology. 2016;21(7):1255–1261.
  • Polke M, Rötting M, Sarmand N, et al. Interventional therapy in patients with severe emphysema: evaluation of contraindications and their incidence. Ther Adv Respir Dis. 2019;13:1753466619835494. doi:10.1177/1753466619835494
  • Slebos DJ, Shah PL, Herth FJ, Valipour A. Endobronchial valves for endoscopic lung volume reduction: best practice recommendations from expert panel on endoscopic lung volume reduction. Respiration. 2017;93(2):138–150. doi:10.1159/000453588
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD; 2022.
  • Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet. 2003;361(9361):931–933. doi:10.1016/S0140-6736(03)12762-6
  • Aryal S, Diaz-Guzman E, Mannino DM. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis. 2014;14(9):1145–1154.
  • Cydulka RK, Rowe BH, Clark S, Emerman CL, Rimm AR, Camargo CA. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbations. Acad Emerg Med. 2005;12(12):1173–1179. doi:10.1197/j.aem.2005.06.025
  • Patil SP, Krishnan JA, Lechtzin MD, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 2003;163(10):1180–1186. doi:10.1001/archinte.163.10.1180
  • Theilig DC, Huebner RH, Neumann K, Poellinger A, Doellinger F. Selecting patients for lobar lung volume reduction therapy: what quantitative computed tomography parameters matter? Rofo. 2019;191(1):40–47. doi:10.1055/a-0638-0058